COVID-19 vaccine development: What lessons can we learn from TB?

被引：0
作者：
Hussain A. Safar
Abu Salim Mustafa
Timothy D. McHugh
机构：
[1] University College London,Centre for Clinical Microbiology, Division of Infection and Immunity
[2] Kuwait University,Department of Microbiology, Faculty of Medicine
来源：
Annals of Clinical Microbiology and Antimicrobials | / 19卷
关键词：
COVID-19; SARS-CoV-2; Tuberculosis; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
At the time of writing, the SARS-CoV-2 virus has infected more than 49 million people causing more than 1.2 million deaths worldwide since its emergence from Wuhan, China in December 2019. Vaccine development against SARS-CoV-2 has drawn the global attention in order to stop the spread of the virus, with more than 10 vaccines being tested in phase III clinical trials, as of November 2020. However, critical to vaccine development is consideration of the immunological response elicited as well as biological features of the vaccine and both need to be evaluated thoroughly. Tuberculosis is also a major infectious respiratory disease of worldwide prevalence and the vaccine development for tuberculosis has been ongoing for decades. In this review, we highlight some of the common features, challenges and complications in tuberculosis vaccine development, which may also be relevant for, and inform, COVID-19 vaccine development.
引用
收藏
相关论文
共 296 条
[1]  
Furin J(2019)Tuberculosis Lancet. 393 1642-1656
[2]  
Cox J(2020)An overview of COVID-19 J Zhejiang Univ Sci B. 21 343-360
[3]  
Pai M(2014)The contribution of vaccination to global health: past, present and future Phil Trans Royal Soc B 369 20130433-273
[4]  
Shi Y(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-506
[5]  
Wang G(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet. 395 497-41
[6]  
Cai X(2020)Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts J Leukoc Biol 108 17-1524
[7]  
Deng J(2020)Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis J Med Virol 92 1518-374
[8]  
Zheng L(2020)The trinity of COVID-19: immunity, inflammation and intervention Nat Rev Immunol 20 363-846
[9]  
Zhu H(2012)Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? Viruses. 4 833-432
[10]  
Greenwood B(2020)Coronavirus infections and immune responses J Med Virol 92 424-30006
12345678910